Pegasus Partners »

Ocular Therapeutix shares owned by Pegasus Partners

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Pegasus Partners from 13F filings

Historical chart of Pegasus Partners investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Pegasus Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Pegasus Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $112k 25k 4.46

More positions owned by Pegasus Partners

Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 3000 Etf (IWV)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Rus Tp200 Vl Etf (IWX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus Top 200 Etf (IWL)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Ishares Tr Rus Mdcp Val Etf (IWS)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)

View all positions for Pegasus Partners

Top funds holding Ocular Therapeutix

VR Adviser
Summer Road
Opaleye Management
Vanguard Group
Franklin Resources
Logos Global Management
Citadel Advisors
Deltec Asset Management
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Banco Santander
Artia Global Partners
D. E. Shaw & Co
Essex Investment Management
Bank of New York Mellon

View all funds holding Ocular Therapeutix